Info

BioPort manufactures the only FDA-licensed anthrax vaccine in the world. We are also making and testing vaccine . . . to protect against five different types of botulism, . . . It is probably next on the threat list behind anthrax and the rapidly emerging threat of smallpox. . . . [B]ecause smallpox is highly contagious and probably most of the world is now susceptible, it is a potential biowarfare agent of serious concern. . . . There exist similar challenges to the further development and manufacture of new vaccines for anthrax, smallpox, and, for that matter, any other biodefense vaccine. . . . Suppose we have a smallpox vaccine stockpile and a manufacturing capability.